Encapsulating Peritoneal Sclerosis (EPS)
Keywords:
Encapsulating Peritoneal Sclerosis (EPS), Peritoneal dialysis, Duration of the peritoneal dialysis, bio-incompatibility solutionAbstract
Encapsulating Peritoneal Sclerosis (EPS) is a rare disease in peritoneal dialysis patients. However, the mortality rate of this condition is more than 50% in the 1-year follow-up period. The pathogenesis of the disease is unclear. The major risk factors are the duration of the peritoneal dialysis, history of peritonitis and bio-incompatibility PD solution. The pathology of EPS is the disappearance of mesothelial cells with fibrin adhesion that attaches to the intestinal tract and visceral organs. There are no definite definitions of EPS. Diagnosis require two components, which are intestinal obstruction or ileus and physical changes of the peritoneal from radiographic imaging. The best predictor of EPS is duration of PD treatment, an increase in peritoneal solute transport rate (PSTR) and an increase in creatinine D / P ratio. However, any biomarker can’t be used to predict or screen for EPS. Current treatment depends on the stage of the disease. It is recommended that all EPS patients should stop peritoneal dialysis. Steroids or tamoxifen may be benefit for EPS when combined nutritional therapy. Finally, surgical treatment by a specialist surgeon is recommended if the symptom does not improve.
Downloads
References
Augustine T, Brown PW, Davies SD, Summers AM, Wilkie ME. Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin Pract. 2009;111(2):c149-154; discussion c154. https://doi.org/10.1159/000191214
Gandhi VC, Humayun HM, Ing TS, et al. Sclerotic Thickening of the Peritoneal Membrane in Maintenance Peritoneal Dialysis Patients. Arch Intern Med. 1980;140(9):1201-1203. https://doi.org/10.1001/archinte.1980.00330200077024
Alatab S, Najafi I, Pourmand G, Hosseini M, Shekarchian S. Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients. Ren Fail. 2017;39(1):32-39. https://doi.org/10.1080/0886022X.2016.1244075
Kitterer D, Braun N, Alscher MD, Segerer S, Latus J. The number of patients with severe encapsulating peritoneal sclerosis is decreasing in a large referral center in Germany. Int J Nephrol Renov Dis. 2016;9:183-186. https://doi.org/10.2147/IJNRD.S108529
Petrie MC, Traynor JP, Mactier RA. Incidence and outcome of encapsulating peritoneal sclerosis. Clin Kidney J. 2016;9(4):624-629. https://doi.org/10.1093/ckj/sfw051
Vizzardi V, Sandrini M, Zecchini S, Ravera S, Manili L, Cancarini G. Encapsulating peritoneal sclerosis in an Italian center: thirty year experience. J Nephrol. 2016;29(2):259-267. https://doi.org/10.1007/s40620-015-0241-x
Nakayama M, Miyazaki M, Honda K, et al. Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study. Perit Dial Int J Int Soc Perit Dial. 2014;34(7):766-774. https://doi.org/10.3747/pdi.2013.00074
Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int J Int Soc Perit Dial. 2000;20 Suppl 4:S43-55.
Honda K, Hamada C, Nakayama M, et al. Impact of Uremia, Diabetes, and Peritoneal Dialysis Itself on the Pathogenesis of Peritoneal Sclerosis: A Quantitative Study of Peritoneal Membrane Morphology. Clin J Am Soc Nephrol CJASN. 2008;3(3):720-728. https://doi.org/10.2215/CJN.03630807
Brown EA, Van Biesen W, Finkelstein FO, et al. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD. Perit Dial Int J Int Soc Perit Dial. 2009;29(6):595-600.
Lambie MR, Chess J, Summers AM, et al. Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL Fluid Study. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2016;31(3):480-486. https://doi.org/10.1093/ndt/gfv440
Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int J Int Soc Perit Dial. 2005;25 Suppl 4:S19-29.
Kawanishi K, Honda K, Hamada C. Recommendations for pathological diagnosis on biopsy samples from peritoneal dialysis patients. Pleura Peritoneum. 2017;2(1):3-15. https://doi.org/10.1515/pp-2016-0028
Moinuddin Z, Summers A, Van Dellen D, Augustine T, Herrick SE. Encapsulating peritoneal sclerosis-a rare but devastating peritoneal disease. Front Physiol. 2014;5:470. https://doi.org/10.3389/fphys.2014.00470
Nakamoto H. Encapsulating peritoneal sclerosis--a clinician’s approach to diagnosis and medical treatment. Perit Dial Int J Int Soc Perit Dial. 2005;25 Suppl 4:S30-38.
Kawaguchi Y, Saito A, Kawanishi H, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int J Int Soc Perit Dial. 2005;25 Suppl 4:S83-95.
Tarzi RM, Lim A, Moser S, et al. Assessing the Validity of an Abdominal CT Scoring System in the Diagnosis of Encapsulating Peritoneal Sclerosis. Clin J Am Soc Nephrol CJASN. 2008;3(6):1702-1710. https://doi.org/10.2215/CJN.01820408
Vlijm A, Stoker J, Bipat S, et al. Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int J Int Soc Perit Dial. 2009;29(5):517-522.
Goodlad C, Tarzi R, Gedroyc W, Lim A, Moser S, Brown EA. Screening for encapsulating peritoneal sclerosis in patients on peritoneal dialysis: role of CT scanning. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2011;26(4):1374-1379. https://doi.org/10.1093/ndt/gfq533
Ti JP, Al-Aradi A, Conlon PJ, Lee MJ, Morrin MM. Imaging features of encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. AJR Am J Roentgenol. 2010;195(1):W50-54. https://doi.org/10.2214/AJR.09.3175
Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int J Int Soc Perit Dial. 2005;25 Suppl 4:S39-47.
Goodlad C, Brown EA. Encapsulating peritoneal sclerosis: what have we learned? Semin Nephrol. 2011;31(2):183-198. https://doi.org/10.1016/j.semnephrol.2011.01.007
Brown EA, Bargman J, van Biesen W, et al. Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis - Position Paper for ISPD: 2017 Update. Perit Dial Int J Int Soc Perit Dial. 2017;37(4):362-374. https://doi.org/10.3747/pdi.2017.00018
Lambie ML, John B, Mushahar L, Huckvale C, Davies SJ. The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made. Kidney Int. 2010;78(6):611-618. https://doi.org/10.1038/ki.2010.186
Sampimon DE, Korte MR, Barreto DL, et al. Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int J Int Soc Perit Dial. 2010;30(2):163-169. https://doi.org/10.3747/pdi.2009.00022
Goodlad C, Tam FWK, Ahmad S, Bhangal G, North BV, Brown EA. Dialysate Cytokine Levels Do Not Predict Encapsulating Peritoneal Sclerosis. Perit Dial Int J Int Soc Perit Dial. 2014;34(6):594-604. https://doi.org/10.3747/pdi.2012.00305
Yamamoto T, Nagasue K, Okuno S, Yamakawa T. The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis. Perit Dial Int J Int Soc Perit Dial. 2010;30(3):343-352. https://doi.org/10.3747/pdi.2008.00273
Kawanishi H, Kawaguchi Y, Fukui H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis Off J Natl Kidney Found. 2004;44(4):729-737.
Korte MR, Fieren MW, Sampimon DE, et al. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2011;26(2):691-697. https://doi.org/10.1093/ndt/gfq362
Balasubramaniam G, Brown EA, Davenport A, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2009;24(10):3209-3215. https://doi.org/10.1093/ndt/gfp008
Kawanishi H, Shintaku S, Moriishi M, Dohi K, Tsuchiya S. Seventeen years’ experience of surgical options for encapsulating peritoneal sclerosis. Adv Perit Dial Conf Perit Dial. 2011;27:53-58.
de Freitas D, Jordaan A, Williams R, et al. Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis. Perit Dial Int J Int Soc Perit Dial. 2008;28(3):271-276.
Johnson DW, Cho Y, Livingston BER, et al. Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int. 2010;77(10):904-912. https://doi.org/10.1038/ki.2010.16
Downloads
Published
How to Cite
Issue
Section
License
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของราชวิทยาลัยจุฬาภรณ์
ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับราชวิทยาลัยจุฬาภรณ์ และคณาจารย์ท่านอื่น ในราชวิทยาลัยฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใด ๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
